The use of medicinal plants for the treatment of diseases including malaria is commonplace in Ghanaian traditional medicine, though the therapeutic claims for most plants remain unvalidated.
This study describes the genetic diversity of Plasmodium falciparum isolates from uncomplicated malaria cases over a ten year period (2003–2013) in Ghana using the polymorphic antigenic marker, merozoite surface protein 2 (msp2).
The SMC intervention is economically beneficial in reducing morbidity in children under-5 years and presents a viable approach to improving under-five health in Ghana.
HBC showed greater utilization by children under-five years of age in the Volta Region while CHPS was more utilized in the Northern Region.
These results indicate that children living in urban setting may experience a greater anemic effect to malaria as compared with those living in a rural setting.
The prevalence of P. falciparum parasitaemia is 10 % in healthy blood donors in the Akatsi district and represents a risk for TTM though the extent of this risk is unclear.
Limited health system capacity, socio-economic, political, and historical factors hampered malaria RDT implementation at primary care facilities in the study district.
There is no clear cut trajectory for management of uncomplicated malaria in the study area. Different approaches are adopted when treating malaria.
A high number of P. falciparum parasites, which lack pfhrp2 exon 2 gene have been identified in two communities in Ghana.
The total cost of treating fever/malaria episode is relatively high in the study area considering the poverty levels in Ghana.